Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2

Data Availability

Pseudonymised data are accessible via Combined Intelligence for Population Health Action (CI-PHA). Requests can be made to the Data Asset and Access Group for extracts of the larger-scale data which cannot be released openly due to information governance requirements. All R code is accessible from the corresponding author.